A Randomized Phase II Study of Everolimus for Advanced Pancreatic Neuroendocrine Tumors in Chinese Patients
- Type
- Retraction
- Notice date
- 7/21/2015 0:00
- Journal
- Medical Oncology
- Publisher
- Springer
- Notice DOI
- 10.1007/s12032-015-0661-4
- Original paper DOI
- 10.1007/s12032-014-0251-x